Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial Academic Article 2015 uri icon

authors

  • Perez-Molina JA.
  • Troya J.
  • Mariño A.
  • Antela A.
  • Navarro J.
  • Esteban H.
  • Moreno S.
  • GESIDA 7011 Study Group
  • BOIX MARTINEZ, VICENTE
  • Rubio R.
  • Rivero A.
  • Pasquau J.
  • Suárez-Lozano I.
  • Riera M.
  • Estébanez M.
  • Santos J.
  • Sanz-Moreno J.

publication date

  • 2015